Added to Saved items
This page has been archived. It has not been updated since 19/08/2011. External links and references may no longer work.
This article is for Medical Professionals

Professional Reference articles are designed for health professionals to use. They are written by UK doctors and based on research evidence, UK and European Guidelines. You may find one of our health articles more useful.

Read COVID-19 guidance from NICE

Treatment of almost all medical conditions has been affected by the COVID-19 pandemic. NICE has issued rapid update guidelines in relation to many of these. This guidance is changing frequently. Please visit https://www.nice.org.uk/covid-19 to see if there is temporary guidance issued by NICE in relation to the management of this condition, which may vary from the information given below.

Synonyms: rheumatoid pneumoconiosis, silicoarthritis and rheumatoid lung silicosis

This is pulmonary fibrosis, usually in coal miners who have rheumatoid arthritis (RA). The syndrome is named after Dr Tony Caplan who was a doctor on the pneumoconiosis board in Cardiff.[1] There are a few earlier papers on the subject, calling it Caplan's syndrome. It seems to have been discovered in the 1950s.

It was said to affect 1 in 100,000 people but the incidence is falling as the coal mining industry has been in decline. The prevalence is so low that much of the literature is case reports rather than trials. PubMed lists no more than 20 papers in the past 10 years.

Rheumatoid arthritis (RA) is a systemic disease and not just a disease of joints. The combination of RA and exposure to coal dust produces the condition. It develops especially in miners working in anthracite coal mines and in persons exposed to silica and asbestos.[2] There is probably also a genetic predisposition and smoking is thought to be an aggravating factor.

Symptoms

There is cough and shortness of breath. In addition there are the features of rheumatoid arthritis (RA) with painful joints and morning stiffness.

Signs

There are features of RA, including tender swollen metacarpophalangeal (MCP) joints and rheumatoid nodules. The nodules may pre-date the appearance of RA by several years. Examination of the chest may show diffuse rales that do not disappear on coughing or taking a deep breath.

The combination of rheumatoid arthritis (RA) and exposure to coal dust are essential for the diagnosis but silicosis and asbestosis must be considered. The X-ray appearance can resemble tuberculosis (TB).

In RA, lung disease can develop even in the absence of dust exposure. It includes interstitial fibrosis, pleural effusion, pulmonary nodules, pulmonary arteritis and pulmonary hypertension.[3]

CXR shows multiple, round, well-defined nodules, usually 0.5-2.0 cm in diameter, which may cavitate and resemble tuberculosis (TB). CT scanning gives a better picture of cavitation.[4]

Spirometry may reveal a mixed restrictive and obstructive ventilatory defect with a loss of lung volume. There may also be irreversible airflow limitation and a reduced gas transfer factor.

Rheumatoid factor, antinuclear antibodies, and non-organ specific antibodies may be present in the blood. ESR or PV and CRP will be elevated. X-rays of affected joints will show the features of rheumatoid arthritis (RA) with bone erosions.

Tuberculosis (TB) must be sought and treated if found.

Nondrug

  • Exposure to coal dust must cease.
  • Physical treatment should proceed as for rheumatoid arthritis (RA).
  • Smoking should cease.

Drugs

After exclusion of TB, steroids are used. Treatment of the RA will include disease-modifying anti-rheumatic drugs (DMARDs) at an early stage.

Tuberculosis (TB) may co-exist. There can be complications from steroids and other forms of treatment, whether non-steroidal anti-inflammatory drugs (NSAIDs) or DMARDs.

This is as for RA. Severe respiratory disability is uncommon but massive pulmonary fibrosis can progress at times. Spontaneous remission of the lung disease can occur.

People with rheumatoid arthritis (RA) must not be exposed to additional risk factors for lung disease.

Further reading and references

  1. Caplan A; Rheumatoid disease and pneumoconiosis (Caplan's syndrome). Proc R Soc Med. 1959 Dec52:1111-3.

  2. Ondrasik M; Caplan's syndrome. Baillieres Clin Rheumatol. 1989 Apr3(1):205-10.

  3. Lee JH, Suh GY, Lee KY, et al; Small airway disease in rheumatoid arthritis. Korean J Intern Med. 1992 Jul7(2):87-93.

  4. Arakawa H, Honma K, Shida H, et al; Computed tomography findings of Caplan syndrome. J Comput Assist Tomogr. 2003 Sep-Oct27(5):758-60.

newnav-downnewnav-up